Federal Supply Schedule 36F79720D0227
Award Date
9/15/20
Last Date to Order
9/14/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Exelan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,164,262.95 and a period of performance from February 22, 2024 to February 21, 2026. The purpose of this contract is to procure oseltamivir phosphate capsules and suspension for distribution to the VA, Department of Defense...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award, unrestricted Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $48,442,917.75, is for the supply of Escitalopram Oxalate Tablets in various package sizes to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The single-award IDC, valued at up to $6,984,109.81, has an ultimate completion date of February 11, 2029. Under this contract, Exelan Pharmaceuticals will provide a variety of generic pharmaceutical products to the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted IDC has a ceiling value of $4,792,297.44 and a period of performance through December 19, 2025. The contract covers the delivery of a variety of generic pharmaceutical products, including Dofetilide Capsules, to the VA, Department of...
This Indefinite Delivery Contract (IDC) award to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, was issued by the Defense Logistics Agency (DLA) with a ceiling value of $5,592,523.40 and a period of performance through June 7, 2026. The contract is for the manufacture and distribution of various pharmaceutical products, primarily generic medications such as ibuprofen, citalopram, oseltamivir phosphate, and alfuzosin HCl, to support federal healthcare programs...
The federal contract IDV award SPE2D219D0070 was granted to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The IDV is a single-award indefinite delivery contract with a ceiling value of $45,158,494.05 and an ultimate completion date of May 28, 2024. Exelan Pharmaceuticals, a key supplier of generic and branded pharmaceutical products to various federal healthcare agencies, will deliver a diverse range of pharmaceutical items...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award contract, valued at a ceiling of $12,802,166.10, is for the delivery of Ramipril capsules in various strengths and package sizes. The period of performance is from March 14, 2022, to March 13, 2023, with four one-year option periods. The...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
The federal contract IDV was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical company based in Boca Raton, Florida. The contract, with a ceiling value of $15,582,998.52, is for the provision of ibuprofen and related pharmaceutical repackaging services to support the VA's Pharmaceutical Repackaging Program. This single-award, indefinite delivery contract does not utilize any set-aside designations....
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract is valued at a ceiling of $52,330,802.25 and has a period of performance from June 15, 2020 to June 14, 2025, including a base year and four one-year option periods. The contract is for the supply of Diclofenac NA 1% Gel...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79720D0227-36E79721N0022 | Exelan Pharmaceuticals Inc. | $46.8k | 3/5/21 | 4/30/21 | 3/5/21 | |
Delivery Order 36F79720D0227-36E79721N0016 | Exelan Pharmaceuticals Inc. | $29.9k | 2/3/21 | 3/17/21 | 2/3/21 | |
Delivery Order 36F79720D0227-36E79721N0030 | Exelan Pharmaceuticals Inc. | $29.9k | 4/7/21 | 6/30/21 | 4/7/21 | |
Delivery Order 36F79720D0227-36E79721N0034 | Exelan Pharmaceuticals Inc. | $39.1k | 5/5/21 | 6/3/21 | 5/5/21 | |
Delivery Order 36F79720D0227-36E79721N0044 | Exelan Pharmaceuticals Inc. | $19.3k | 7/7/21 | 8/30/21 | 7/7/21 |